ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 160 filers reported holding ANTARES PHARMA INC in Q2 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,225,000 | -9.7% | 1,194,530 | -8.1% | 2.07% | -24.3% |
| Q2 2020 | $3,573,000 | +183.1% | 1,299,202 | +244.3% | 2.74% | +1.2% |
| Q3 2019 | $1,262,000 | +39.3% | 377,399 | +37.0% | 2.70% | +450.9% |
| Q2 2019 | $906,000 | +40.9% | 275,425 | +38.0% | 0.49% | -35.6% |
| Q2 2017 | $643,000 | – | 199,655 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |